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A B S T R A C T
BACKGROUND AND PURPOSE: Neuromuscular ultrasound in amyotrophic lateral sclerosis (ALS) is of increasing interest.
As bulbar symptoms are commonly developed by most ALS patients during disease, the aim of our study was to find possible
sonographic changes of vagus nerve size in bulbar affected ALS patients.
METHODS: We investigated 24 ALS patients and 19 controls without neuromuscular disorders. In ALS patients, bulbar affection
was documented clinically (eg, dysarthria, dysphagia, and fasciculations) or subclinically using ultrasound and electromyography
of bulbar muscles. Vagus nerve ultrasound was performed in all participants bilaterally at the level of the thyroid gland.
RESULTS: The cross-sectional area (CSA) of the vagus nerve in bulbar affected ALS patients (mean CSA right/left 1.9 ± .7
mm2/1.8 ± .6 mm2) was significantly reduced on both sides compared to controls (mean CSA right/left 2.2 ± .6 mm2/2.0 ±
.3 mm2) – right: P = .0387, left: P = .0386. Receiver operating characteristic curve analysis of the vagus nerve CSA yielded a
sensitivity of 66.7% and a specificity of 63.2% (cutoff value 1.85 mm2). Vagus nerve CSA did not correlate significantly with age
in controls (right: P = .45, left: P = .66). In controls and ALS patients, there was no significant difference of vagus nerve CSA
between the right and left sides (controls: P = .43; patients: P = .86).
CONCLUSION: Our study demonstrates vagus nerve atrophy in bulbar affected ALS patients. Further studies are warranted
investigating the relevance of our finding for monitoring disease progression in ALS.
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Amyotrophic lateral sclerosis (ALS) is a neuromuscular disor-
der affecting motor neurons of the spinal cord, lower brainstem,
and cerebral cortex.
Involvement of bulbar muscles is commonly identified by
needle electromyography (EMG) of several muscles, includ-
ing the genioglossus, sternocleidomastoid, upper trapezius, and
frontalis muscle.1 Additionally, muscle ultrasound (MUS) has
proved to be a useful tool for the detection of fasciculations,
but the detection of bulbar involvement in ALS may still be
difficult.2,3 Nerve ultrasound (NUS) has been useful in the dis-
tinction of ALS from multifocal motor neuropathy and in quan-
tifying disease progression.4,5 Vagus nerve sonography could be
a valuable tool in diagnosing bulbar ALS patients as it may re-
flect degeneration of motor fibers supplying pharyngeal and la-
ryngeal muscles. As there is preliminary sonographic evidence
from a case report that the vagus nerve is reduced in size in ALS
patients with bulbar involvement, the aim of present study was
to confirm possible changes in the vagus nerve size in a series
of bulbar affected ALS patients.6 This study could be the basis
for further research of vagus nerve changes in ALS patients as
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Between May 2017 and December 2019, 24 patients (mean
age: 64 years) referred for evaluation of ALS to the Depart-
ment of Neurology and Clinical Neurophysiology, University
of Augsburg, Germany, were examined. Patients were classi-
fied by clinical, electrophysiological, and ultrasound examina-
tions according to the Awaji criteria.7 Disease duration reached
from 2 to 48 months. Ten patients already had clinical signs
of bulbar involvement (such as bulbar dysarthria and dyspha-
gia), 14 patients had no bulbar symptoms clinically but were
affected based on pathologic MUS and EMG. Extensive clin-
ical, laboratory, and imaging examinations were performed to
exclude patients with other differential diagnoses. For detecting
bulbar involvement, the patients underwent EMG studies (ge-
nioglossus and frontalis muscle), MUS of the floor of the mouth,
and vagus NUS. A group of 19 subjects with other neurological
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Fig 1. Axial scan of the vagus nerve. Axial scan of the vagus nerve
laterally to the carotid artery and dorsally to the internal jugular vein
within the carotid sheath. CSA = 1.8 mm2. CA, carotid artery; IJV,
internal jugular vein.
diseases (headache, epilepsy, and transitory ischemic attack)
and without a history of neuromuscular disorders served as con-
trols. Controls were selected age-matched as a correlation of
vagus nerve size and age has been shown previously.8 Subjects
with diagnosed diabetes mellitus or injuries of the neck were
excluded. The study was approved by the ethics committee of
the University of Augsburg. All participants provided written
informed consent.
To evaluate the degree of functional impairment, the ALS
Functional Rating Scale (ALSFRS-R, 0 = worst, 48 = best) was
performed for each patient as well as the bulbar subscale of
the ALSFRS-R assessing bulbar impairment (0 = worst, 12 =
best).9,10
EMG, Vagus Nerve Ultrasound, and Muscle Ultrasound
For EMG studies, we used a Schwarzer Topas EMG (Natus
Europe, Planegg, Germany). An experienced electromyogra-
pher performed all EMG examinations with a concentric nee-
dle electrode using standard settings and bandpass of 20 Hz-10
kHz with an amplifier sensitivity of 100 µV/division.1
For evaluation of bulbar involvement, the frontalis muscle
and the tongue were examined according to Pan et al.1
Ultrasound examinations were performed by an experi-
enced examiner using a Philips IU22 ultrasound machine
with a 17-MHz linear-array transducer. Sonography of the
floor of the mouth was performed visualizing in a trans-
verse view the digastric muscle, mylohyoid muscle, genio-
hyoid, and genioglossus muscle, as well as the base of the
tongue. The fasciculations on ultrasound were classified as
involuntary twitching of small parts of the muscle lasting
for .2-.5 seconds according to O’Gorman et al.3 Exploration
time was 90 seconds. The presence of fasciculations was
defined by the detection of more than two fasciculations
during scantime.
Vagus NUS was performed using the same ultrasound de-
vice and a linear-array transducer (17 MHz) as in MUS. The
cross-sectional area (CSA) of the right and left vagus nerves
was measured at the level of the thyroid gland in the carotic
sheath.8 As anatomic landmarks, the carotid artery and the
Table 1. Demographic and Clinical Data of the Participants
Parameter Controls (n = 19) Patients (n = 24)
Sex (male); n (%) 13 (68.4%) 16 (66.7%)
Age (years) 63.05 ± 11.07 64.04 ± 9.98
Disease duration (months) NA 12.46 ± 10.28
Bulbar symptoms; n (%) NA 10 (41.7%)
ALSFRS-R NA 41.63 ± 5.03
ALSFRS-R bulbar NA 10.46 ± 2.43
Note: Age, disease duration, ALSFRS-R, and ALSFRS-R bulbar data are pre-
sented as mean ± standard deviation, unless otherwise indicated. Sex and bulbar
affection are presented as number (percentage). n, number of subjects; NA, not
applicable.
Table 2. Vagus Nerve Cross-Sectional Area (mm2) in Controls and Pa-
tients
Vagus nerve, right thyroid Vagus nerve, left thyroid
Maximum Minimum Mean ± SD Maximum Minimum Mean ± SD
Controls 3.5 1.5 2.2 ± .6 2.6 1.5 2.0 ± .3
(n = 19)
ALS 4.0 .9 1.9 ± .7 4.0 1.2 1.8 ± .6
patients
(n = 24)
P P = .0387 (s) P = .0386 (s)
Note: P-values ≤ .05 for comparisons between controls and patients were consid-
ered statistically significant. SD, standard deviation; s, significant; n, number of
subjects.
internal jugular vein were used (Fig 1). The nerves were scanned
by the author in the supine position in axial planes. CSA was
traced inside the (hyper)echogenic epineural rim of the nerve.
At all sites, CSA was measured three times, and values were
averaged.
Statistical Analysis
For statistical analysis, GraphPad Prism 4 software was used.
Means and standard deviation of the vagus nerve CSA were
determined. The Mann-Whitney U-test was performed to com-
pare controls and patients and ALS patients with and without
bulbar symptoms. Statistical significance was defined as P ≤ .05.
Pearson correlation coefficient was calculated to correlate
CSA measurements with the age of controls. P-values were cal-
culated by Pearson correlation test and P ≤ .05 was considered
statistically significant.
To show the diagnostic accuracy of vagus NUS in differen-
tiating controls and patients, a receiver operating characteristic
(ROC) curve was used for the right vagus nerve.
Results
The study included 24 patients with bulbar ALS and 19 healthy
volunteers. The degree of functional impairment reached from
24 to 49 in the ALSFRS-R (mean: 41.6), bulbar affection
reached from 12 (only affected in EMG and MUS) to 2 (mean:
10.5) in the ALSFRS-R bulbar subscore. Table 1 shows some
clinical and demographic data of patients and controls. In con-
trols, vagus nerve CSA did not correlate significantly with age
(right: P = .45, left: P = .66).
Table 2 shows the results of the CSA values of the vagus
NUS. In both, controls and ALS patients, vagus nerve CSA was
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Fig 2. Box plots of the cross-sectional area of the vagus nerve at
the level of the thyroid gland. A: right side; B: left side. The data
show the CSA in controls and patients with amyotrophic lateral scle-
rosis (ALS) at the level of the right (A) and the left (B) thyroid gland.
Median (line at the middle), 25th-75th percentiles (box), and range
(error bars) are shown. P-value (P = .0387 on the right and P =
.0386 on the left side) indicates significance level for the comparison
of patients and controls. Significance was set at P ≤ .05.
slightly but nonsignificantly larger on the right compared to the
left side (controls: P = .43; patients: P = .86).
Figure 2 shows the box plots of the CSA of the vagus nerve
at the level of the right (A) and the left (B) thyroid gland in
patients and controls. The CSA of the right and left vagus nerves
was significantly smaller in patients compared to controls (right
side: P = .0387, left side: P = .0386).
There was no significant difference between ALS patients
with and without bulbar symptoms in vagus nerve CSA on both
sides (P = .0532 on the right, P = .2779 on the left).
ROC curve analysis of the vagus nerve CSA showed low
diagnostic accuracy of vagus NUS (AUC = .69, Fig 3). A cutoff
value of < 1.85 mm2 resulted in a sensitivity of 66.7% and a
specificity of 63.2%. A cutoff value of < 1.55 mm2 showed a
specificity of 94.7% (sensitivity: 37.5%).
Fig 3. ROC curve for vagus nerve ultrasound. Area under the ROC
curve: .69 (low accuracy), P-value .03769. A cutoff value for the
vagus nerve CSA of 1.85 mm2 yielded a sensitivity of 66.7% and
a specificity of 63.2%. ROC, receiver-operator characteristic; CSA,
cross-sectional area.
Discussion
In our study, we could show vagal atrophy in exclusively bulbar
affected ALS patients. CSA of the vagus nerve was significantly
reduced compared to controls at the level of the thyroid gland
on both sides.
Bulbar involvement was detected by an elaborate protocol
combining needle EMG and ultrasound for the detection of
fasciculations as demonstrated by Kido et al also including the
frontalis muscle to increase diagnostic accuracy, as patients are
able to relax this muscle more easily than the tongue in EMG
studies.1,11 Bulbar MUS has proved to be useful for the assess-
ment of upper neuron involvement, and fasciculations became
part of the diagnostic criteria of ALS in 2008.3,7,12
To our knowledge, this is the first study of vagus NUS in a se-
ries of exclusively bulbar affected ALS patients confirming pre-
liminary data from a single case report that showed a markedly
reduced vagus nerve diameter in an exclusively bulbar-affected
patient (CSA: 1 mm2 on both sides).6 Grimm et al examined
CSA in a group of 17 ALS patients and controls and reported a
trend toward lower CSA values in ALS patients; however, no
significant difference was found.4 As they did not provide spe-
cific information about bulbar involvement or disease severity,
these data cannot be easily compared to our results.
In healthy subjects, vagus NUS was examined by Pelz et al
and reference values were determined at the level of the thy-
roid gland. CSA values of our controls at the level of the thy-
roid gland were comparable to their healthy subjects older than
50 years (range: 50-76 years; our controls: range 42-87 years,
mean age of 63 years).8 Higher values for vagus nerve CSA
as reported by Cartwright et al may be explained by different
study cohorts as discussed by Pelz et. al.8,13
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There is no clear evidence whether vagus nerve size varies
with age. We did not find a significant correlation between va-
gus nerve size and age in our controls (mean age: 63 years),
which is in line with the study by Walter et al (mean age: 45
years) investigating vagal atrophy in Parkinson patients and
healthy subjects.14 Although there was a trend to smaller nerve
CSAs with increasing age, the difference was statistically not
significant. In contrast, Pelz et al reported a significant and neg-
ative correlation between vagus nerve size and age (mean age:
49 years).8
A possible explanation of the vagal atrophy could be a de-
generation of motor fibers originating in the brainstem (nucleus
ambiguous) and supplying pharyngeal and laryngeal muscles in
bulbar affected ALS patients. Brainstem degeneration has been
described a pathognomonic feature in most motoneuron dis-
eases as shown, for example, by MRI morphometric studies.15
As the autonomic nervous system does not show major involve-
ment in ALS patients, atrophy of autonomic nerve fibers (as
shown, eg, in diabetes patients) is unlikely the reason for vagal
nerve atrophy.16,17
ROC curve analysis of vagus NUS revealed low accuracy.
A cutoff value of vagus nerve CSA of 1.85 mm2 achieved a sen-
sitivity of 66.7% and a specificity of 63.2%. Higher accuracy
maybe achieved, including more severely affected patients re-
vealing more vagal atrophy. In our study, we examined rela-
tively mild affected patients as can be seen in the ALSFRS-R
(mean 41.63) and ALSFRS-R bulbar subscale (mean 10.46). Ad-
ditionally, disease duration was short (mean: 12.46 months). In
order to avoid these limitations, further studies are warranted
investigating a higher proportion of patients with lower scores,
with longer disease duration and increasing the number of pa-
tients in general. In our study, there was also no significant dif-
ference in vagus nerve CSA between patients with and without
clinical signs of bulbar involvement. Future studies will show
whether more severely bulbar affected patients exhibit a more
pronounced vagus nerve atrophy.
A limitation of our study could be that ultrasound was only
performed by a single experienced sonographer. However, Pelz
et al have shown in a previous study that vagus nerve measure-
ment at the level of thyroid gland has high interrater reliability.8
Blinding to clinical findings or EMG was difficult as many of
our patients had obvious signs of a motor neuron disorder, in-
cluding weakness and muscle atrophy.
Another limitation of our study is that patients were only in-
vestigated at a time. In our study, marked vagal atrophy (< 1.55
mm2) was observed in some patients without bulbar symptoms.
Observation over a longer period of time will be necessary to
show if these patients reveal a faster disease progression.
In conclusion, bulbar ALS completes the spectrum of disor-
ders associated with vagus nerve atrophy beyond Parkinson’s
disease and diabetes mellitus.14,17 In order to investigate a pos-
sible correlation between vagal nerve and brainstem atrophy,
further studies combining NUS and MRI should be performed.
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